INTANGIBLE ASSETS (Details) (USD $)	9 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]
Cost	$ 9,980,000
Accumulated Amortization	355,000
Total	9,625,000	9,625,000
Estimated amortization expense
2013
2014
2015	1,069,000
2016	2,139,000
2017	2,139,000
ResearchMember
Finite-Lived Intangible Assets [Line Items]
Cost	355,000
Accumulated Amortization	355,000
Total
PatentsMember
Finite-Lived Intangible Assets [Line Items]
Cost	1,305,000
Accumulated Amortization
Total	1,305,000
DrugMember
Finite-Lived Intangible Assets [Line Items]
Cost	1,500,000
Accumulated Amortization
Total	1,500,000
PharmaceuticalMember
Finite-Lived Intangible Assets [Line Items]
Cost	6,820,000
Accumulated Amortization
Total	6,820,000
PatentedTechnologyMember
Finite-Lived Intangible Assets [Line Items]
Cost	9,625,000
Accumulated Amortization
Total	9,625,000
IntangibleassetsMember
Finite-Lived Intangible Assets [Line Items]
Cost	9,980,000
Accumulated Amortization	355,000
Total	$ 9,625,000